ChemoMetec A/S (CPH: CHEMM)
Denmark
· Delayed Price · Currency is DKK 374.60
-5.60 (-1.47%)
Aug 30, 2024, 4:59 PM CET
ChemoMetec Income Statement
Financials in millions DKK. Fiscal year is July - June.
Millions DKK. Fiscal year is Jul - Jun.
Fiscal Year | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Operating Revenue | 400.95 | 442.27 | 427.16 | 281.13 | 214.1 | 175.51 | Upgrade
|
| Other Revenue | 0.59 | 2.13 | 1.23 | - | - | - | Upgrade
|
| Revenue | 401.54 | 444.4 | 428.39 | 281.13 | 214.1 | 175.51 | Upgrade
|
| Revenue Growth (YoY) | -12.94% | 3.74% | 52.38% | 31.31% | 21.99% | 55.75% | Upgrade
|
| Cost of Revenue | 47.43 | 49.01 | 44.14 | 27.78 | 20.18 | 16.89 | Upgrade
|
| Gross Profit | 354.11 | 395.39 | 384.25 | 253.34 | 193.92 | 158.62 | Upgrade
|
| Selling, General & Admin | 155.25 | 144.36 | 161.36 | 117.71 | 97.31 | 93.73 | Upgrade
|
| Operating Expenses | 173.67 | 164.83 | 181.4 | 137.32 | 112.45 | 104.54 | Upgrade
|
| Operating Income | 180.44 | 230.56 | 202.85 | 116.02 | 81.47 | 54.08 | Upgrade
|
| Interest Expense | -2.02 | -1.09 | -1.52 | -0.92 | -1.19 | -0.72 | Upgrade
|
| Interest & Investment Income | 6.57 | 2.46 | 0.01 | 0.09 | 0.05 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.57 | -1.57 | 1.87 | -2.46 | -0.41 | 0.33 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 0 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 183.43 | 230.36 | 203.22 | 112.73 | 79.92 | 53.71 | Upgrade
|
| Other Unusual Items | - | - | - | - | -4 | - | Upgrade
|
| Pretax Income | 183.43 | 230.36 | 203.22 | 112.73 | 75.92 | 53.71 | Upgrade
|
| Income Tax Expense | 39.63 | 51.69 | 43.75 | 24.38 | 16.76 | 11.87 | Upgrade
|
| Net Income | 143.8 | 178.67 | 159.47 | 88.35 | 59.16 | 41.85 | Upgrade
|
| Net Income to Common | 143.8 | 178.67 | 159.47 | 88.35 | 59.16 | 41.85 | Upgrade
|
| Net Income Growth | -19.98% | 12.04% | 80.49% | 49.34% | 41.39% | 129.73% | Upgrade
|
| Shares Outstanding (Basic) | 17 | 17 | 17 | 17 | 17 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 17 | 17 | 17 | 17 | 16 | Upgrade
|
| Shares Change (YoY) | 0.04% | - | - | 3.23% | 8.35% | 0.27% | Upgrade
|
| EPS (Basic) | 8.26 | 10.27 | 9.16 | 5.08 | 3.51 | 2.69 | Upgrade
|
| EPS (Diluted) | 8.26 | 10.27 | 9.16 | 5.08 | 3.51 | 2.69 | Upgrade
|
| EPS Growth | -19.98% | 12.08% | 80.42% | 44.66% | 30.49% | 129.87% | Upgrade
|
| Free Cash Flow | 131.96 | 132.97 | 137.76 | 96.65 | 57.73 | 43.15 | Upgrade
|
| Free Cash Flow Per Share | 7.58 | 7.64 | 7.92 | 5.55 | 3.42 | 2.77 | Upgrade
|
| Dividend Per Share | 6.000 | 6.000 | - | 4.000 | 1.500 | 7.500 | Upgrade
|
| Dividend Growth | - | - | - | 166.67% | -80.00% | - | Upgrade
|
| Gross Margin | 88.19% | 88.97% | 89.70% | 90.12% | 90.57% | 90.38% | Upgrade
|
| Operating Margin | 44.94% | 51.88% | 47.35% | 41.27% | 38.05% | 30.81% | Upgrade
|
| Profit Margin | 35.81% | 40.20% | 37.23% | 31.43% | 27.63% | 23.84% | Upgrade
|
| Free Cash Flow Margin | 32.86% | 29.92% | 32.16% | 34.38% | 26.96% | 24.59% | Upgrade
|
| EBITDA | 192.2 | 244.49 | 216.65 | 129.01 | 91.93 | 61.16 | Upgrade
|
| EBITDA Margin | 47.87% | 55.02% | 50.57% | 45.89% | 42.94% | 34.84% | Upgrade
|
| D&A For EBITDA | 11.76 | 13.93 | 13.8 | 12.98 | 10.46 | 7.08 | Upgrade
|
| EBIT | 180.44 | 230.56 | 202.85 | 116.02 | 81.47 | 54.08 | Upgrade
|
| EBIT Margin | 44.94% | 51.88% | 47.35% | 41.27% | 38.05% | 30.81% | Upgrade
|
| Effective Tax Rate | 21.61% | 22.44% | 21.53% | 21.63% | 22.07% | 22.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.